Compared side by side

MK-677 vs CJC-1295 no DAC: how they differ

Reviewed How we check the libraryPublished by PepVault

The short answer

They raise growth hormone through different receptors: MK-677 is a small molecule (not a peptide) that mimics ghrelin and is taken by mouth once a day, and CJC-1295 no DAC is a GHRH analogue injected 2–3 times a day for pulse-like GH release. MK-677’s effect on GH and IGF-1 lasts about a day, while the no-DAC form is short-acting. Commonly reported: strong hunger and water retention on MK-677, and a flush or head rush within minutes of injecting CJC-1295 no DAC.

Side by side

ComparedMK-677CJC-1295 no DAC
CategoryGrowth hormoneGrowth hormone
Also known asIbutamoren, Nutrobal, MK677, Ibutamoren MesylateModified GRF 1-29, Mod GRF 1-29, CJC-1295 without DAC
What it isNot actually a peptide — it's a small molecule you take orally that mimics ghrelin to stimulate GH release.The shorter-acting version of CJC-1295, meant to give sharp, pulse-like GH release.
How it worksOrally active ghrelin receptor agonist and GH secretagogue. Stimulates GH and IGF-1 with little short-term effect on cortisol (a small rise over a year). Its long-lasting effect on GH and IGF-1 allows once-daily oral dosing. Significantly increases appetite and promotes deep sleep. MK-677 is a small molecule GH secretagogue, not a peptide — included because it is extremely commonly tracked alongside peptide GH protocols.GHRH analogue without the DAC modification. Its half-life in people hasn't been measured (native GHRH lasts minutes), and the short action gives pulse-like GH release. Usually stacked with Ipamorelin to mimic natural GH secretion patterns.
Commonly reportedStrong hunger, especially in the first weeks; water retention with puffy hands and feet or tingling hands; and deeper sleep with vivid dreams, sometimes with morning grogginess. Once-daily dosing boosts natural GH pulses and keeps IGF-1 elevated.A flush or head rush within minutes of injecting, deeper sleep and vivid dreams early on, and mild water retention over the weeks. The no-DAC form itself has no published human studies.
Studied rangeResearch range: 10–25 mg, starting dose 10 mg. Studied in research — not a recommendation.Research range: 100–200 mcg. Studied in research — not a recommendation.
How oftenDaily, before bed2–3x daily
Half-life~24 hours (community estimate; no half-life has been published for people: in dogs it was 4–6 hours, and its effect on GH and IGF-1 lasts about a day)~30 min (community estimate; not measured in people: sermorelin, the unmodified 1-29 chain, lasts 11–12 minutes)
RouteOralSubQ injection
Typical runContinuous use common (oral convenience). Some cycle 3 months on / 1 month off. Long-term safety data limited.8–12 weeks typical. Usually stacked with Ipamorelin; cycle both together.
EvidenceModerate: animal studies + some human dataModerate: animal studies + some human data
Common side effectsIncreased appetite, water retention, lethargy, elevated fasting glucose, vivid dreams, carpal tunnel symptomsWater retention, headache, flushing, injection site pain

Typical run: Community practice — opinions vary. Not a clinical recommendation.

A smiling man in a grey t-shirt in his living room, holding his phone

PepVault for iPhone

Taking MK-677 or CJC-1295 no DAC? Log it in PepVault

Each dose, each vial and your step-ups in one place.

Download on the App Store

7 days free on the yearly plan for new subscribers.

Week by week

Each entry’s cards by day window, as the compound pages show them. Day 1 is the day you start it.

MK-677

  • Day 1–14 Hunger up, sleep deeper, water on
  • Day 14–56 Lean mass is climbing
  • Day 56–90 Check your labs — glucose is the watch item

Every card for MK-677, with its sources

CJC-1295 no DAC

  • Day 1–14 Sleep usually moves first
  • Day 14–28 Recovery is quicker, skin looks better
  • Day 28–56 Body composition starts shifting
  • Day 56–84 Cycle endpoint

Every card for CJC-1295 no DAC, with its sources

Together or one or the other

MK-677 and CJC-1295 no DAC are a common stack: MK-677 lists CJC-1295 no DAC among its common stacks.

Questions people ask

How long do MK-677 and CJC-1295 no DAC last?

The half-life of MK-677 is ~24 hours (community estimate; no half-life has been published for people: in dogs it was 4–6 hours, and its effect on GH and IGF-1 lasts about a day). The half-life of CJC-1295 no DAC is ~30 min (community estimate; not measured in people: sermorelin, the unmodified 1-29 chain, lasts 11–12 minutes).

How often are MK-677 and CJC-1295 no DAC taken?

MK-677: daily, before bed. Route: Oral. CJC-1295 no DAC: 2–3x daily. Route: SubQ injection.

How are MK-677 and CJC-1295 no DAC dosed in research?

The research range for MK-677 is 10–25 mg, with a 10 mg starting dose. The research range for CJC-1295 no DAC is 100–200 mcg. Studied in research — not a recommendation.

What are the common side effects of MK-677 and CJC-1295 no DAC?

For MK-677, the library lists: increased appetite, water retention, lethargy, elevated fasting glucose, vivid dreams, carpal tunnel symptoms. For CJC-1295 no DAC: water retention, headache, flushing, injection site pain.

Are MK-677 and CJC-1295 no DAC taken together?

MK-677 and CJC-1295 no DAC are a common stack: MK-677 lists CJC-1295 no DAC among its common stacks.

Each one in full

Track it in the app

PepVault for iPhone

Taking MK-677 or CJC-1295 no DAC? Log it in PepVault

Each dose, each vial and your step-ups in one place.

Download on the App Store

7 days free on the yearly plan for new subscribers.

Explore the live demo